Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/10/1/47/19477127/10-1-47.pdf
Reference26 articles.
1. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm;Mauriac;Ann Oncol,1991
2. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6;Scholl;Eur J Cancer,1994
3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Chn Oncol,1997
4. Apport de la drill-biopsie dans le bilan pretherapeutique des adenocarcinomes mammaires;Mauriac;Bull Cancer (Paris),1981
5. Primary chemotherapy in breast invasive carcinoma: Predictive value of the immuno-histochemical detection of hormonal receptors, p53, c-erb-B2, MiB1, pS2 and GST;MacGrogan;Br J Cancer,1996
Cited by 381 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Omission of breast surgery in exceptional responders;Clinical Breast Cancer;2024-02
2. Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis;Journal of Surgical Research;2024-01
3. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?;Indian Journal of Surgical Oncology;2023-09-29
4. Accuracy of Tumor Bed Biopsy for Predicting Pathologic Complete Response After Chemotherapy Among Women With Breast Cancer: Complete Responders in the Breast Study;JCO Global Oncology;2023-09
5. Locoregional Treatment for Early-Stage Breast Cancer: Current Status and Future Perspectives;Current Oncology;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3